Development of diagnostic kits for fusion gene detection in haematooncology (Q10134)

From EU Knowledge Graph
Revision as of 15:38, 28 October 2020 by DG Regio (talk | contribs) (‎Removed claim: financed by (P890): Directorate-General for Regional and Urban Policy (Q8361), Removing unnecessary financed by statement)
Jump to navigation Jump to search
Project Q10134 in Czech Republic
Language Label Description Also known as
English
Development of diagnostic kits for fusion gene detection in haematooncology
Project Q10134 in Czech Republic

    Statements

    0 references
    10,223,960.0 Czech koruna
    0 references
    408,958.4 Euro
    10 January 2020
    0 references
    17,780,800.0 Czech koruna
    0 references
    711,232.0 Euro
    10 January 2020
    0 references
    57.5 percent
    0 references
    1 July 2016
    0 references
    29 September 2019
    0 references
    GENERI BIOTECH s.r.o.
    0 references
    0 references

    50°11'18.20"N, 15°49'54.80"E
    0 references
    50011
    0 references
    Cílem projektu je vývoj prototypů diagnostických souprav pro detekci a kvantifikaci fúzních genů v hematoonkologii. Za účelem zvýšení výkonnostních parametrů vyšetření budou využity inovace z oblasti oligonukleotidových syntéz, převážně modifikace teploty tání a purifikace po syntéze. Pro řešení budou využity technologie real-time PCR, digitální PCR a sekvenování nové generace. Zavedením těchto souprav do nabídky očekáváme zvýšení konkurenceschopnosti firmy na českém i zahraničním trhu. a. (Czech)
    0 references
    The aim of the project is to develop prototypes of diagnostic kits for detection and quantification of fusion genes in hematooncology. In order to increase the performance parameters of the examination, innovations from oligonucleotide synthesis, mainly melting temperature modification and synthesis purification will be used. Real-time PCR, digital PCR and next generation sequencing will be used for the solution. By introducing these trains into the offer we expect to increase the competitiveness of the company on the Czech and foreign markets. (English)
    22 October 2020
    0 references

    Identifiers

    CZ.01.1.02/0.0/0.0/15_018/0004927
    0 references